LISCure is a biotechnology company that develops and commercializes immunotherapy drugs for oncology and CNS disorders.
Business Model:
Revenue: $4.5M
Employees: 11-50
Address: 4F, 68, Pangyo-ro 255beon-gil,
City: Seongnam
State: gyeonggido
Zip: 13286
Country: KR
LISCure is a biotechnology company that develops and commercializes immunotherapy drugs for oncology and CNS disorders.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2021 | Series B | $21M | 7/2019 | Seed | 3 | $5M |
Shinhan Investment KB Securities NHN Investment KB Securities NHN Investment Shinhan Investment |
11/2020 | Series A | $1.8M |
Intron Bio Technologies |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|